Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The person is willing and able to sign a written consent form before the study begins
- The person is a female aged 18 years or older
- The person has been diagnosed with primary breast cancer (confirmed by tissue testing) that can be treated with surgery, with a tumour size of 1 cm or larger
- The person has a specific type of breast cancer called "triple-negative," meaning the tumour tests negative for certain hormone receptors (ER and PR) and a protein called HER2 (confirm with trial site for exact testing details)
- The person is planned to receive chemotherapy before surgery (with or without immunotherapy), as decided by their treating team
- Tumour tissue samples preserved in a standard way are available for central testing, or the tumour can be accessed for a biopsy
- The person is able to follow the study requirements, including completing questionnaires about how they are feeling
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- The person has already received any treatment for this breast cancer, including surgery, radiotherapy, chemotherapy, or hormone treatments
- The person has taken antibiotic tablets or received antibiotics through a drip within the 14 days before being enrolled in the trial
- The person has breast cancer that has already spread to other parts of the body (distant metastases)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melissa Phillips, Barts & The London NHS Trust
Phone: 020 7882 8489
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determining the changes in the gut microbiome following treatment; Determining the changes in the gut microbiome following treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.